Radx blueprint medtech translator cohort 1 - commercialization center
Ended Awarded Last action
- Contract number
- 75N92024F00003
- Awardee
-
National Collegiate Inventors & Innovators Alliance, Inc. UEI D5S9JZ1KDP49
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $478,706
Award facts
- Opportunity
-
- 75N92024R0290 Solicitation number
- Contract value 100% obligated
- $478,705.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute of Biomedical Imaging and Bioenginering National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541618 Other Management Consulting Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Hadley, MA 01035, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $478,706 |
About this award
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a delivery order valued at $478,705.90 to National Collegiate Inventors & Innovators Alliance, Inc. (doing business as Venturewell) on July 17, 2024, for the RADX Blueprint MedTech Translator Cohort 1 - Commercialization Center. The contract is a firm fixed-price delivery order with no small business set-aside designation and is scheduled for completion by June 30, 2026. Venturewell, a nonprofit organization based in Hadley, Massachusetts, will perform the work at that same location. This award represents a continuation of NIBIB's support for Venturewell's role in advancing diagnostic technology commercialization initiatives.
This delivery order is issued under a larger indefinite delivery contract (IDC) framework between NIBIB and Venturewell focused on establishing and operating commercialization centers as part of the Rapid Acceleration of Diagnostics (RADx) initiative. Venturewell's expertise in innovation program management, technology commercialization support, and entrepreneurship training makes the organization well-suited to support the MedTech Translator Cohort, which aims to accelerate the development and commercial viability of emerging biomedical diagnostic technologies. The RADX initiative, a federal effort to expand diagnostic testing capacity and innovation in response to public health priorities, leverages Venturewell's established track record of managing similar commercialization and technology acceleration programs for NIH institutes.
Quick answers
Who was awarded contract 75N92024F00003?
75N92024F00003 was awarded to National Collegiate Inventors & Innovators Alliance, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on July 17, 2024.
How much is contract 75N92024F00003 worth?
The government has obligated $478,706 on 75N92024F00003.
Which agency awarded contract 75N92024F00003?
National Heart Lung and Blood Institute (National Institutes of Health) awarded 75N92024F00003, with funding from National Institute of Biomedical Imaging and Bioenginering (National Institutes of Health).
Is contract 75N92024F00003 an order under another contract?
Yes. 75N92024F00003 is a delivery order under 75N92022D00013, an indefinite delivery contract.
Was contract 75N92024F00003 competed?
The extent of competition for 75N92024F00003 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award